These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30626016)

  • 1. Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease.
    Cappellano G; Comi C; Chiocchetti A; Dianzani U
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotoxicity of poly (lactic-co-glycolic acid) nanoparticles: influence of surface properties on dendritic cell activation.
    Barillet S; Fattal E; Mura S; Tsapis N; Pallardy M; Hillaireau H; Kerdine-Römer S
    Nanotoxicology; 2019 Jun; 13(5):606-622. PubMed ID: 30760076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles.
    Kabiri M; Sankian M; Sadri K; Tafaghodi M
    Eur J Pharm Biopharm; 2018 Dec; 133():321-330. PubMed ID: 30408519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model.
    Liu Q; Wang X; Liu X; Kumar S; Gochman G; Ji Y; Liao YP; Chang CH; Situ W; Lu J; Jiang J; Mei KC; Meng H; Xia T; Nel AE
    ACS Nano; 2019 Apr; 13(4):4778-4794. PubMed ID: 30964276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses.
    Gu P; Wusiman A; Wang S; Zhang Y; Liu Z; Hu Y; Liu J; Wang D
    Carbohydr Polym; 2019 Nov; 223():115128. PubMed ID: 31427012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Customizing poly(lactic-co-glycolic acid) particles for biomedical applications.
    Swider E; Koshkina O; Tel J; Cruz LJ; de Vries IJM; Srinivas M
    Acta Biomater; 2018 Jun; 73():38-51. PubMed ID: 29653217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antigen-specific immune tolerance using biodegradable nanoparticles containing antigen and dexamethasone.
    Kim SH; Moon JH; Jeong SU; Jung HH; Park CS; Hwang BY; Lee CK
    Int J Nanomedicine; 2019; 14():5229-5242. PubMed ID: 31371958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
    Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
    AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
    Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; Renò F; Dianzani U
    Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLGA-Based Composites for Various Biomedical Applications.
    Rocha CV; Gonçalves V; da Silva MC; Bañobre-López M; Gallo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.
    Ding D; Zhu Q
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():1041-1060. PubMed ID: 30184728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
    Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
    J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles.
    Li X; Jiang X
    Adv Drug Deliv Rev; 2018 Mar; 128():101-114. PubMed ID: 29277543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
    Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
    Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Poly(acyclic orthoester)s: Acid-Sensitive Biomaterials for Enhancing Immune Responses of Protein Vaccine.
    Xing Y; Xu Z; Liu T; Shi L; Kohane D; Guo S
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7235-7239. PubMed ID: 32061182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.